A

Aprea Therapeutics
D

APRE

2.67000
USD
0.03
(1.14%)
مغلق
حجم التداول
171
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
14,511,191
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARVN
    -0.600
    (-3.27%)
    17.750 USD
    A
    ASND
    -2.390
    (-1.54%)
    152.440 USD
    A
    ATRA
    -0.42000
    (-5.58%)
    7.11000 USD
    A
    AUTL
    0.01500
    (0.77%)
    1.96000 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BPMC
    -2.080
    (-2.20%)
    92.280 USD
    C
    CRNX
    0.660
    (1.79%)
    37.470 USD
    المزيد
الأخبار
المقالات

العنوان: Aprea Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.